Literature DB >> 18200569

Liver function tests in patients with bacteremia.

Shinichiro Kanai1, Takayuki Honda, Takeshi Uehara, Takehisa Matsumoto.   

Abstract

The purpose of this study was to evaluate liver function tests as potential indicators of bacteremia. We examined 156 patients with laboratory-confirmed bacteremia (bacteremia group) and 211 bacteremia-negative patients with bacterial infections (control group). The patients of the two groups had no underlying liver diseases. For patients in the bacteremia group, we analyzed liver function tests results obtained the day when the first positive blood culture was ordered. For those in the control group, the same data were obtained on the day when the first of multiple negative blood cultures was ordered. At t-test analyses, serum levels of gamma-glutamyl transpeptidase (gamma-GT) and alkaline phosphatase (ALP) were significantly higher, and those of albumin, total cholesterol, and cholinesterase were significantly lower in the bacteremia group than in the control group. Multivariate analyses found serum cholinesterase as an independent factor with adjusted odds ratio of 0.319 (per 65 U/L, standard deviation [SD] size). Serum level of C-reactive protein (CRP), on the other hand, showed no significant difference between the two groups. Serum levels of gamma-GT, ALP, albumin, total cholesterol, and cholinesterase more rapidly altered when various bacterial infections accompanied bacteremia. Therefore, they may be useful in detecting sepsis in its early stages. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18200569      PMCID: PMC6649175          DOI: 10.1002/jcla.20205

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  16 in total

Review 1.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

2.  THE POSSIBLE BIOLOGICAL FUNCTION OF PSEUDOCHOLINESTERASE.

Authors:  J W CLITHEROW; M MITCHARD; N J HARPER
Journal:  Nature       Date:  1963-09-07       Impact factor: 49.962

Review 3.  Physicochemical and pathophysiological factors in the release of membrane-bound alkaline phosphatase from cells.

Authors:  D W Moss
Journal:  Clin Chim Acta       Date:  1997-01-03       Impact factor: 3.786

Review 4.  Clinical issues of blood cultures.

Authors:  P H Chandrasekar; W J Brown
Journal:  Arch Intern Med       Date:  1994-04-25

5.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

Authors:  S Harbarth; K Holeckova; C Froidevaux; D Pittet; B Ricou; G E Grau; L Vadas; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

6.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

7.  Procalcitonin: a valuable indicator of infection in a medical ICU?

Authors:  E Suprin; C Camus; A Gacouin; Y Le Tulzo; S Lavoue; A Feuillu; R Thomas
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

8.  Degradation of acetylcholine in human airways: role of butyrylcholinesterase.

Authors:  X Norel; M Angrisani; C Labat; I Gorenne; E Dulmet; F Rossi; C Brink
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

9.  Jaundice and the sepsis syndrome: a neglected link.

Authors:  Giuseppe Famularo; Claudio De Simone; Giulio Cesare Nicotra
Journal:  Eur J Intern Med       Date:  2003-07       Impact factor: 4.487

10.  Cryptogenic acute cholangitis--association with toxic shock syndrome.

Authors:  K G Ishak; W A Rogers
Journal:  Am J Clin Pathol       Date:  1981-11       Impact factor: 2.493

View more
  7 in total

Review 1.  Liver involvement in systemic infection.

Authors:  Masami Minemura; Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Hepatol       Date:  2014-09-27

2.  Extracellular activation of arginase-1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation.

Authors:  Keita Miki; Abhai Kumar; Runkuan Yang; Meaghan E Killeen; Russell L Delude
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-08-27       Impact factor: 4.052

Review 3.  Liver in systemic disease.

Authors:  Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

4.  Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients.

Authors:  Lijun Xu; Biao Zhu; Ying Huang; Zongxing Yang; Jia Sun; Yan Xu; Jinlei Zheng; Sabine Kinloch; Michael T Yin; Honglei Weng; Nanping Wu
Journal:  Mediators Inflamm       Date:  2018-03-15       Impact factor: 4.711

5.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

6.  Association between early serum cholinesterase activity and 30-day mortality in sepsis-3 patients: A retrospective cohort study.

Authors:  Zheng-Liang Peng; Liang-Wei Huang; Jian Yin; Ke-Na Zhang; Kang Xiao; Guo-Zhong Qing
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

7.  Early Detection of Bacteraemia Using Ten Clinical Variables with an Artificial Neural Network Approach.

Authors:  Kyoung Hwa Lee; Jae June Dong; Su Jin Jeong; Myeong-Hun Chae; Byeong Soo Lee; Hong Jae Kim; Sung Hun Ko; Young Goo Song
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.